Transmission of resistant HIV

Transmission of drug-resistant strains of HIV is well-documented. While studies from the late 1990s suggested that less than 10% of new infections d drug-resistant virus, recent studies suggest that many newly infected individuals are infected with an at least somewhat drug-resistant strain of HIV. As the uptake of antiretroviral therapy has spread, so has the transmission of drug-resistant virus.

(The overall prevalence of resistant virus, as opposed to transmitted resistant virus, is discussed above: see Limiting the chance of resistance.)

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.